Form 8-K - Current report:
SEC Accession No. 0001625297-25-000042
Filing Date
2025-06-24
Accepted
2025-06-24 16:52:40
Documents
15
Period of Report
2025-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K indv-20250620.htm   iXBRL 8-K 38057
2 EX-99.1 ex991pressreleaseindiviora.htm EX-99.1 11684
3 EX-99.2 a99210b5-1purchaseplanneds.htm EX-99.2 109546
4 EX-99.3 a993sideletter.htm EX-99.3 27735
  Complete submission text file 0001625297-25-000042.txt   329156

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20250620.xsd EX-101.SCH 1773
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20250620_lab.xml EX-101.LAB 21615
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20250620_pre.xml EX-101.PRE 12502
17 EXTRACTED XBRL INSTANCE DOCUMENT indv-20250620_htm.xml XML 2737
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37835 | Film No.: 251069853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)